共 50 条
- [2] Effectiveness of intralasional Talimogene Laherparepvec and systemic PD-1 Antibody Therapy after Progress under adjuvant PD-1 Antibody Therapy in malignant Melanoma: 3 Case Reports JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 31 - 31
- [3] PROGNOSTIC ANALYSIS OF PD-1 ANTIBODY IN THE COMBINATION TREATMENT OF PRIMARY MALIGNANT MELANOMA OF ESOPHAGUS ACTA MEDICA MEDITERRANEA, 2021, 37 (04): : 2303 - 2308
- [8] Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer FRONTIERS IN IMMUNOLOGY, 2021, 12
- [10] Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma? MEDICINA-LITHUANIA, 2022, 58 (10):